Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-26

Clinical Trial Update: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) [Phase 3]

View source ↗

Summary

Clinical trial update indicating that Fasedienol nasal spray is being studied for acute treatment of social anxiety disorder in a Phase 3 PALISADE-3 trial and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fasedienol nasal spray (fasedienol)

Snippet

Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING